bupivacaine hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-001294
A drug used to relieve pain by blocking signals at nerve endings. It is being studied in the relief of pain following surgery for cancer. It is a type of local anesthetic. Also called Marcaine and Sensorcaine.
A long-acting, amide-type local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.
| Identifier | MLC-T-ONC-001294 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Marcaine; Sensorcaine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001294",
"term": "bupivacaine hydrochloride",
"field": "Oncology and biomedicine",
"definitions": [
"A drug used to relieve pain by blocking signals at nerve endings. It is being studied in the relief of pain following surgery for cancer. It is a type of local anesthetic. Also called Marcaine and Sensorcaine.",
"A long-acting, amide-type local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation."
],
"synonyms": [
"Marcaine",
"Sensorcaine"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bupivacaine-hydrochloride/"
}
Record 3,946 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.